Targeting MOG expression to dendritic cells delays onset of experimental autoimmune disease

References

• Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001; 345:340–350.
   PubMed Web of Science ®Google Scholar
• Rose NR, Mackay IR. The autoimmune diseases. 4th ed. San Diego, CA: Elsevier Academic Press; 2006.
   Google Scholar
• Casetta I, Iuliano G, Filippini G. Azathioprine for multiple sclerosis. Cochrane Database Syst Rev. 20074: CD003982.
   Google Scholar
• Schacke H, Docke WD, Asadullah K. Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther. 2002; 96:23–43.
   PubMed Web of Science ®Google Scholar
• Alaez C, Loyola M, Murguia A, Flores H, Rodriguez A, Ovilla R, Ignacio G, Amador R, Salinas V, Perez F, Rodriguez D, Morales Z, Llinguin G, Vazquez A, Altamirano A, Gorodezky C. Hematopoietic stem cell transplantation (HSCT): An approach to autoimmunity. Autoimmun Rev. 2006; 5:167–179.
   PubMed Web of Science ®Google Scholar
• Mancardi G, Saccardi R. Autologous haematopoietic stem-cell transplantation in multiple sclerosis. Lancet Neurol. 2008; 7:626–636.
   PubMed Web of Science ®Google Scholar
• Nash RA, McSweeney PA, Crofford LJ, Abidi M, Chen CS, Godwin JD, Gooley TA, Holmberg L, Henstorf G, LeMaistre CF, Mayes MD, McDonagh KT, McLaughlin B, Molitor JA, Nelson JL, Shulman H, Storb R, Viganego F, Wener MH, Seibold JR, Sullivan KM, Furst DE. High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for severe systemic sclerosis: Long-term follow-up of the US multicenter pilot study. Blood. 2007; 110:1388–1396.
   PubMed Web of Science ®Google Scholar
• Dazzi F, Tyndall A. Cell therapy for autoimmune diseases. Arthritis Res Ther. 2007; 9:206.
   PubMed Web of Science ®Google Scholar
• Marmont AM, Burt RK. Hematopoietic stem cell transplantation for systemic lupus erythematosus, the antiphospholipid syndrome and bullous skin diseases. Autoimmunity. 2008; 41:639–647.
   PubMed Web of Science ®Google Scholar
• Blanco Y, Saiz A, Carreras E, Graus F. Autologous haematopoietic-stem-cell transplantation for multiple sclerosis. Lancet Neurol. 2005; 4:54–63.
   PubMed Web of Science ®Google Scholar
• Tyndall A, Saccardi R. Haematopoietic stem cell transplantation in treatment of severe autoimmune disease: Results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol. 2005; 141:1–9.
   PubMed Web of Science ®Google Scholar
• Couzin J. Immunology. Gently soothing a savage immune system. Science. 2002; 296:456–458.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M. Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med. 2002; 346:1185–1193.
   PubMed Web of Science ®Google Scholar
• Aiuti A, Cattaneo F, Galimberti S, Benninghoff U, Cassani B, Callegaro L, Scaramuzza S, Andolfi G, Mirolo M, Brigida I, Tabucchi A, Carlucci F, Eibl M, Aker M, Slavin S, Al-Mousa H, Al Ghonaium A, Ferster A, Duppenthaler A, Notarangelo L, Wintergerst U, Buckley RH, Bregni M, Marktel S, Valsecchi MG, Rossi P, Ciceri F, Miniero R, Bordignon C, Roncarolo MG. Gene therapy for immunodeficiency due to adenosinen deaminase deficiency. N Engl J Med. 2009; 360:447–458.
   PubMed Web of Science ®Google Scholar
• Chan J, Ban EJ, Chun KH, Wang B, Backstrom BT, Bernard C, Toh BH, Alderuccio F. Transplantation of bone marrow transduced to express self-antigen establishes deletional tolerance and permanently remits autoimmune disease. J Immmunol. 2008; 181:7571–7580.
   PubMed Web of Science ®Google Scholar
• Xu B, Haviernik P, Wolfraim LA, Bunting KD, Scott DW. Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE. Mol Ther. 2006; 13:42–48.
   PubMed Web of Science ®Google Scholar
• Hacein-Bey-Abina S, Garrigue A, Wang GP, Soulier J, Lim A, Morillon E, Clappier E, Caccavelli L, Delabesse E, Beldjord K, Asnafi V, MacIntyre E, Dal Cortivo L, Radford I, Brousse N, Sigaux F, Moshous D, Hauer J, Borkhardt A, Belohradsky BH, Wintergerst U, Velez MC, Leiva L, Sorensen R, Wulffraat N, Blanche S, Bushman FD, Fischer A, Cavazzana-Calvo M. Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest. 2008; 118:3132–3142.
   PubMed Web of Science ®Google Scholar
• Kohn DB, Candotti F. Gene therapy fulfilling its promise. N Engl J Med. 2009; 360:518–521.
   PubMed Web of Science ®Google Scholar
• Gallegos AM, Bevan MJ. Central tolerance: Good but imperfect. Immunol Rev. 2006; 209:290–296.
   PubMed Web of Science ®Google Scholar
• Proietto AI, van Dommelen S, Wu L. The impact of circulating dendritic cells on the development and differentiation of thymocytes. Immunol Cell Biol. 2009; 87:39–45.
   PubMed Web of Science ®Google Scholar
• Brocker T, Riedinger M, Karjalainen K. Targeted expression of major histocompatibility complex (MHC) class II molecules demonstrates that dendritic cells can induce negative but not positive selection of thymocytes in vivo. J Exp Med. 1997; 185:541–550.
   PubMed Web of Science ®Google Scholar
• Dresch C, Edelmann SL, Marconi P, Brocker T. Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo. J Immunol. 2008; 181:4495–4506.
   PubMedGoogle Scholar
• Kitamura T, Koshino Y, Shibata F, Oki T, Nakajima H, Nosaka T, Kumagai H. Retrovirus-mediated gene transfer and expression cloning: Powerful tools in functional genomics. Exp Hematol. 2003; 31:1007–1014.
   PubMed Web of Science ®Google Scholar
• Yu SF, von Ruden T, Kantoff PW, Garber C, Seiberg M, Ruther U, Anderson WF, Wagner EF, Gilboa E. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells. Proc Natl Acad Sci USA. 1986; 83:3194–3198.
   PubMed Web of Science ®Google Scholar
• Luckashenak N, Schroeder S, Endt K, Schmidt D, Mahnke K, Bachmann MF, Marconi P, Deeg CA, Brocker T. Constitutive crosspresentation of tissue antigens by dendritic cells controls CD8+ T cell tolerance in vivo. Immunity. 2008; 28:521–532.
   PubMed Web of Science ®Google Scholar
• Pear WS, Nolan GP, Scott ML, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA. 1993; 90:8392–8396.
   PubMed Web of Science ®Google Scholar
• Chan J, Clements W, Field J, Lock P, Yap F, Toh BH, Alderuccio F. Transplantation of bone marrow genetically engineered to express proinsulin II protects against autoimmune insulitis in NOD mice. J Gene Med. 2006; 8:1281–1290.
   PubMed Web of Science ®Google Scholar
• Limon A, Briones J, Puig T, Carmona M, Fornas O, Cancelas JA, Nadal M, Garcia J, Rueda F, Barquinero J. High-titer retroviral vectors containing the enhanced green fluorescent protein gene for efficient expression in hematopoietic cells. Blood. 1997; 90:3316–3321.
   PubMed Web of Science ®Google Scholar
• Alderuccio F, Chan J, Toh BH. Tweaking the immune system: Gene therapy-assisted autologous haematopoietic stem cell transplantation as a treatment for autoimmune disease. Autoimmunity. 2008; 41:679–685.
   PubMed Web of Science ®Google Scholar
• Karnezis T, Mandemakers W, McQualter JL, Zheng B, Ho PP, Jordan KA, Murray BM, Barres B, Tessier-Lavigne M, Bernard CC. The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat Neurosci. 2004; 7:736–744.
   PubMed Web of Science ®Google Scholar
• Marmont A. Will heamatopoietic stem cell transplantation cure human autoimmune diseases?. J Autoimmun. 2008; 30:145–150.
   PubMed Web of Science ®Google Scholar
• Alderuccio F, Chan J, Scott DW, Toh BH. Gene therapy and bone marrow stem-cell transfer to treat autoimmune disease. Trends Mol Med. 2009; 15:344–351.
   PubMed Web of Science ®Google Scholar
• Gallegos AM, Bevan MJ. Central tolerance to tissue-specific antigens mediated by direct and indirect antigen presentation. J Exp Med. 2004; 200:1039–1049.
   PubMed Web of Science ®Google Scholar
• Stripecke R. Lentiviral vector-mediated genetic programming of mouse and human dendritic cells. Methods Mol Biol. 2009; 506:139–158.
   PubMedGoogle Scholar
• Mukhopadhaya A, Hanafusa T, Jarchum I, Chen YG, Iwai Y, Serreze DV, Steinman RM, Tarbell KV, DiLorenzo TP. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+T cells in NOD mice. Proc Natl Acad Sci USA. 2008; 105:6374–6379.
   PubMed Web of Science ®Google Scholar
• Dhodapkar MV, Steinman RM, Krasovsky J, Munz C, Bhardwaj N. Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells. J Exp Med. 2001; 193:233–238.
   PubMed Web of Science ®Google Scholar
• Hogquist KA, Baldwin TA, Jameson SC. Central tolerance: Learning self-control in the thymus. Nat Rev Immunol. 2005; 5:772–782.
   PubMed Web of Science ®Google Scholar
• Liston A, Lesage S, Wilson J, Peltonen L, Goodnow CC. Aire regulates negative selection of organ-specific T cells. Nat Immunol. 2003; 4:350–354.
   PubMed Web of Science ®Google Scholar
• Zehn D, Bevan MJ. T cells with low avidity for a tissue-restricted antigen routinely evade central and peripheral tolerance and cause autoimmunity. Immunity. 2006; 25:261–270.
   PubMed Web of Science ®Google Scholar
• Bailey SL, Schreiner B, McMahon EJ, Miller SD. CNS myeloid DCs presenting endogenous myelin peptides “preferentially” polarize CD4+T(H)-17 cells in relapsing EAE. Nat Immunol. 2007; 8:172–180.
   PubMed Web of Science ®Google Scholar
• Werner-Klein M, Dresch C, Marconi P, Brocker T. Transcriptional targeting of B cells for induction of peripheral CD8 T cell tolerance. J Immunol. 2007; 178:7738–7746.
   PubMed Web of Science ®Google Scholar
• Song L, Wang J, Wang R, Yu M, Sun Y, Han G, Li Y, Qian J, Scott DW, Kang Y, Soukhareva N, Shen B. Retroviral delivery of GAD-IgG fusion construct induces tolerance and modulates diabetes: A role for CD4+ regulatory T cells and TGF-beta?. Gene Ther. 2004; 11:1487–1496.
   PubMed Web of Science ®Google Scholar
• Melo ME, Qian J, El-Amine M, Agarwal RK, Soukhareva N, Scott DW. Gene transfer of Ig-fusion proteins into B cells prevents and treats autoimmune diseases. J Immunol. 2002; 168:4788–4795.
   PubMed Web of Science ®Google Scholar
• Agarwal RK, Kang Y, Zambidis E, Scott DW, Chan CC, Caspi RR. Retroviral gene therapy with an immunoglobulin-antigen fusion construct protects from experimental autoimmune uveitis. J Clin Invest. 2000; 106:245–252.
   PubMed Web of Science ®Google Scholar
• Perchellet A, Brabb T, Goverman JM. Crosspresentation by nonhematopoietic and direct presentation by hematopoietic cells induce central tolerance to myelin basic protein. Proc Natl Acad Sci USA. 2008; 105:14040–14045.
   PubMed Web of Science ®Google Scholar
• Tian C, Bagley J, Iacomini J. Expression of antigen on mature lymphocytes is required to induce T cell tolerance by gene therapy. J Immunol. 2002; 169:3771–3776.
   PubMed Web of Science ®Google Scholar